Melanoma-pancreatic cancer syndrome: genes and variants
Explore variant evidence for Melanoma-pancreatic cancer syndrome across 1 analyzed protein (CDKN2A). Linked ClinVar records include 11 pathogenic or likely pathogenic variants, 15 variants of uncertain significance and 7 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Melanoma-pancreatic cancer syndrome
CDKN2A: Tumor suppressor ARF
The ARF product of CDKN2A is a tumor-suppressor protein that binds MDM2 and helps preserve p53 activity. By promoting cell-cycle arrest and apoptosis, it provides an important barrier to uncontrolled cell growth from within the nucleolus.
11 ClinVar pathogenic / likely pathogenic and 22 uncertain variants in CDKN2A have source records linked to Melanoma-pancreatic cancer syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Melanoma-pancreatic cancer syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CDKN2A V46G | 46 | Interaction with CDK5RAP3 and MDM2 | Pathogenic / likely pathogenic (★★) |
| CDKN2A R82L | 82 | Pathogenic / likely pathogenic (★★) | |
| CDKN2A R98Q | 98 | Pathogenic / likely pathogenic (★★) | |
| CDKN2A M48I | 48 | Interaction with CDK5RAP3 and MDM2 | Pathogenic / likely pathogenic (★★) |
| CDKN2A S52I | 52 | Interaction with CDK5RAP3 and MDM2 | Pathogenic / likely pathogenic (★★) |
| CDKN2A Q70H | 70 | Pathogenic / likely pathogenic (★★) | |
| CDKN2A A76L | 76 | Pathogenic / likely pathogenic (★★) | |
| CDKN2A L86M | 86 | Pathogenic / likely pathogenic (★★) | |
| CDKN2A R87W | 87 | Pathogenic / likely pathogenic (★★) | |
| CDKN2A G125R | 125 | Pathogenic / likely pathogenic (★★) | |
| CDKN2A S73R | 73 | Pathogenic / likely pathogenic (★★) |
Which prediction tools work for Melanoma-pancreatic cancer syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- SIFT: 79 out of 100
- ESM1b (LLR): 42 out of 100
Same protein, different disease
- Familial melanoma also has ClinVar records linked to CDKN2A variants; they fall in the same places as the Melanoma-pancreatic cancer syndrome variants (15 pathogenic / likely pathogenic).
Diseases related to Melanoma-pancreatic cancer syndrome
- Alzheimer disease, also linked to CDKN2A
- Urinary bladder cancer, also linked to CDKN2A
- Familial melanoma, also linked to CDKN2A
- Non-small cell lung carcinoma, also linked to CDKN2A
- Parkinson disease, also linked to CDKN2A
- Melanoma, cutaneous malignant, also linked to CDKN2A
- Lung adenocarcinoma, also linked to CDKN2A
- Hepatocellular carcinoma, also linked to CDKN2A
- Melanoma and neural system tumor syndrome, also linked to CDKN2A
- Esophageal cancer, also linked to CDKN2A
- Melanoma, also linked to CDKN2A
- Head and neck squamous cell carcinoma, also linked to CDKN2A
Frequently asked questions
Which genes have records linked to Melanoma-pancreatic cancer syndrome?
This view contains 1 analyzed proteins: CDKN2A. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 11 pathogenic or likely pathogenic variants, 15 variants of uncertain significance and 7 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 34 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center